New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ResMed Inc.
RMD
Shape
US Flag

NYSE

35B

Medical - Instruments & Supplies

Next Earning date - 24 Oct 2024

35B

Medical - Instruments & Supplies

Next Earning date - 24 Oct 2024

238.63USD
Shape-0.23 ( -0.10%)
Market Open
favorite-chart

Relative Strenght

72
favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 3, 2024
1W -0.16 % 1M -2.50 % 3M 22.83 % 1Y 62.90 %

Key Metrics

Shape
  • Market Cap

    35.06B


  • Shares Outstanding

    146.93M


  • Share in Float

    145.75M


  • Dividende

    2.12


  • Earning Date

    24 Oct 2024


  • Price Target

    238.625


  • Average Volume

    1.01M


  • Beta

    0.691


  • Range

    132.24-255.18


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.resmed.com


  • Sector

    Healthcare


Fundamentals

Shape

30.87x

P/E Ratio

7.72x

P/S Ratio

7.21x

P/B Ratio

0.2

Debt/Equity

22.5%

Net Margin

$6.9

EPS

How RMD compares to sector?

P/E Ratio

Relative Strength

Shape

RMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape313%

2025-Revenue

$8.81

Shape343%

2025-EPS

$2B

Shape288%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wolfe Research

downgrade

Previous: Peer Perform

2024-09-18

Now: Underperform

Needham

downgrade

Previous: Buy

2024-09-04

Now: Hold

Oppenheimer

downgrade

Previous: Outperform

2024-06-25

Now: Perform

Morgan Stanley

upgrade

Previous: Equal-Weight

2023-10-27

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

1.51
vs 1.51

Q4.22

arrow
arrow

+13%

1.66
vs 1.47

Q1.23

arrow
arrow

+27%

1.68
vs 1.32

Q2.23

arrow
arrow

+7%

1.6
vs 1.49

Q3.23

arrow
arrow

+9%

1.64
vs 1.51

Q4.23

arrow
arrow

+13%

1.88
vs 1.66

Q1.24

arrow
arrow

+27%

2.13
vs 1.68

Q2.24

arrow
arrow

+30%

2.08
vs 1.6

Q3.24

arrow
arrow

+25%

2.05
vs 1.64

Q4.24

arrow
arrow

+21%

2.27
vs 1.88

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

950.3M  vs 904M

Q4.22

arrow
arrow

+16%

1B  vs 894.9M

Q1.23

arrow
arrow

+29%

1.1B  vs 864.5M

Q2.23

arrow
arrow

+23%

1.1B  vs 914.7M

Q3.23

arrow
arrow

+1%

963M  vs 950.3M

Q4.23

arrow
arrow

+12%

1.2B  vs 1B

Q1.24

arrow
arrow

+7%

1.2B  vs 1.1B

Q2.24

arrow
arrow

+9%

1.2B  vs 1.1B

Q3.24

arrow
arrow

+23%

1.2B  vs 963M

Q4.24

arrow
arrow

+8%

1.3B  vs 1.2B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+6%

0.06
vs 0.06

Q4.22

arrow
arrow

+6%

0.06
vs 0.06

Q1.23

arrow
arrow

+6%

0.06
vs 0.06

Q2.23

arrow
arrow

+6%

0.06
vs 0.06

Q3.23

arrow
arrow

+5%

0.05
vs 0.06

Q4.23

arrow
arrow

+5%

0.05
vs 0.05

Q1.24

arrow
arrow

+6%

0.06
vs 0.05

Q2.24

arrow
arrow

+6%

0.06
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

673

673
vs 677

-1%

Q4.22

arrow
arrow

732

732
vs 673

9%

Q1.23

arrow
arrow

680

680
vs 732

-7%

Q2.23

arrow
arrow

740

740
vs 680

9%

Q3.23

arrow
arrow

682

682
vs 740

-8%

Q4.23

arrow
arrow

712

712
vs 682

4%

Q1.24

arrow
arrow

744

744
vs 712

4%

Q2.24

arrow
arrow

785

785
vs 744

6%

Earnings Growth

Latest News